Concepedia

Dan Todd

DT

Statistics

Publications

9

Citations

521

H-Index

9

Active since

2002

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Dan Todd is an author at GlaxoSmithKline (United States) specializing in pharmacology, medicinal chemistry, and ligand binding.

Publications per year

2002–2013

9

Publications

9

Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064

Adwoa Akwabi-Ameyaw, Jonathan Y. Bass, Richard D. Caldwell et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 139 citations · Full text

, , +13

Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir

Eric S. Furfine, Christopher Baker, Michael Hale et al. · Antimicrobial Agents and Chemotherapy · 2004 · 98 citations · Full text

, , +15

FXR agonist activity of conformationally constrained analogs of GW 4064

Adwoa Akwabi-Ameyaw, Jonathan Y. Bass, Richard D. Caldwell et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 61 citations · Full text

, , +14

Conformationally constrained farnesoid X receptor (FXR) agonists: Heteroaryl replacements of the naphthalene

Jonathan Y. Bass, Justin A. Caravella, Lihong Chen et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 60 citations · Full text

, , +14

Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064

Jonathan Y. Bass, Richard D. Caldwell, Justin A. Caravella et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 57 citations · Full text

, , +10

1–5 of 9